132 related articles for article (PubMed ID: 38050080)
1. Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC).
Kohut K; Speight B; Young J; Way R; Wiggins J; Monje-Garcia L; Eccles DM; Foster C; Turner L; Snape K; Hanson H; ;
J Med Genet; 2024 Jan; 61(2):142-149. PubMed ID: 38050080
[TBL] [Abstract][Full Text] [Related]
2. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
Clark A; Thomas S; Hamblin A; Talley P; Kulasekararaj A; Grinfeld J; Speight B; Snape K; McVeigh TP; Snowden JA
Br J Haematol; 2023 Apr; 201(1):35-44. PubMed ID: 36786081
[TBL] [Abstract][Full Text] [Related]
3. Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group.
Speight B; Hanson H; Turnbull C; Hardy S; Drummond J; Khorashad J; Wragg C; Page P; Parkin NW; Rio-Machin A; Fitzgibbon J; Kulasekararaj AG; Hamblin A; Talley P; McVeigh TP; Snape K;
Br J Haematol; 2023 Apr; 201(1):25-34. PubMed ID: 36744544
[TBL] [Abstract][Full Text] [Related]
4. Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice.
Tsoulaki O; Tischkowitz M; Antoniou AC; Musgrave H; Rea G; Gandhi A; Cox K; Irvine T; Holcombe S; Eccles D; Turnbull C; Cutress R; ; Archer S; Hanson H
Br J Cancer; 2024 Jun; ():. PubMed ID: 38834743
[TBL] [Abstract][Full Text] [Related]
5. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes:
Hanson H; Kulkarni A; Loong L; Kavanaugh G; Torr B; Allen S; Ahmed M; Antoniou AC; Cleaver R; Dabir T; Evans DG; Golightly E; Jewell R; Kohut K; Manchanda R; Murray A; Murray J; Ong KR; Rosenthal AN; Woodward ER; Eccles DM; Turnbull C; Tischkowitz M; ; Lalloo F
J Med Genet; 2023 May; 60(5):417-429. PubMed ID: 36411032
[TBL] [Abstract][Full Text] [Related]
6. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
7. Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
Whitworth PW; Beitsch PD; Patel R; Rosen B; Compagnoni G; Baron PL; Simmons R; Brown EA; Gold L; Holmes D; Smith LA; Kinney M; Grady I; Clark P; Barbosa K; Lyons S; Riley L; Coomer C; Curcio L; Ruiz A; Khan S; MacDonald H; Hughes K; Hardwick MK; Heald B; Munro SB; Nielsen SM; Esplin ED
JAMA Netw Open; 2022 Sep; 5(9):e2232787. PubMed ID: 36136330
[TBL] [Abstract][Full Text] [Related]
8. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
Hampel H; Bennett RL; Buchanan A; Pearlman R; Wiesner GL;
Genet Med; 2015 Jan; 17(1):70-87. PubMed ID: 25394175
[TBL] [Abstract][Full Text] [Related]
9. Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer.
Nakken S; Saveliev V; Hofmann O; Møller P; Myklebost O; Hovig E
Int J Cancer; 2021 Dec; 149(11):1955-1960. PubMed ID: 34310709
[TBL] [Abstract][Full Text] [Related]
10. British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for
Sundar S; Manchanda R; Gourley C; George A; Wallace A; Balega J; Williams S; Wallis Y; Edmondson R; Nicum S; Frost J; Attygalle A; Fotopoulou C; Bowen R; Bell D; Gajjar K; Ramsay B; Wood NJ; Ghaem-Maghami S; Miles T; Ganesan R
Int J Gynecol Cancer; 2021 Feb; 31(2):272-278. PubMed ID: 33468564
[TBL] [Abstract][Full Text] [Related]
11. Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.
Bedrosian I; Somerfield MR; Achatz MI; Boughey JC; Curigliano G; Friedman S; Kohlmann WK; Kurian AW; Laronga C; Lynce F; Norquist BS; Plichta JK; Rodriguez P; Shah PD; Tischkowitz M; Wood M; Yadav S; Yao K; Robson ME
J Clin Oncol; 2024 Feb; 42(5):584-604. PubMed ID: 38175972
[TBL] [Abstract][Full Text] [Related]
12. A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.
McVeigh TP; Sweeney KJ; Brennan DJ; McVeigh UM; Ward S; Strydom A; Seal S; Astbury K; Donnellan P; Higgins J; Keane M; Kerin MJ; Malone C; McGough P; McLaughlin R; O'Leary M; Rushe M; Barry MK; MacGregor G; Sugrue M; Yousif A; Al-Azawi D; Berkeley E; Boyle TJ; Connolly EM; Nolan C; Richardson E; Giffney C; Doyle SB; Broderick S; Boyd W; McVey R; Walsh T; Farrell M; Gallagher DJ; Rahman N; George AJ
Fam Cancer; 2023 Apr; 22(2):135-149. PubMed ID: 36029389
[TBL] [Abstract][Full Text] [Related]
13. Report from the UK and Eire Association of Genetic Nurses and Counsellors (AGNC) supervision working group on genetic counselling supervision.
Clarke A; Middleton A; Cowley L; Guilbert P; Macleod R; Clarke A; Tran V;
J Genet Couns; 2007 Apr; 16(2):127-42. PubMed ID: 17308871
[TBL] [Abstract][Full Text] [Related]
14. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
[TBL] [Abstract][Full Text] [Related]
15. Multi-syndrome, multi-gene risk modeling for individuals with a family history of cancer with the novel R package PanelPRO.
Lee G; Liang JW; Zhang Q; Huang T; Choirat C; Parmigiani G; Braun D
Elife; 2021 Aug; 10():. PubMed ID: 34406119
[TBL] [Abstract][Full Text] [Related]
16. Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group.
Bakhuizen JJ; Hanson H; van der Tuin K; Lalloo F; Tischkowitz M; Wadt K; Jongmans MCJ; ; ;
Fam Cancer; 2021 Oct; 20(4):337-348. PubMed ID: 34170462
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.
Geller G; Botkin JR; Green MJ; Press N; Biesecker BB; Wilfond B; Grana G; Daly MB; Schneider K; Kahn MJ
JAMA; 1997 May; 277(18):1467-74. PubMed ID: 9145720
[TBL] [Abstract][Full Text] [Related]
18. Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group.
Taylor A; Brady AF; Frayling IM; Hanson H; Tischkowitz M; Turnbull C; Side L;
J Med Genet; 2018 Jun; 55(6):372-377. PubMed ID: 29661970
[TBL] [Abstract][Full Text] [Related]
19. Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network.
Garrett A; Callaway A; Durkie M; Cubuk C; Alikian M; Burghel GJ; Robinson R; Izatt L; Talukdar S; Side L; Cranston T; Palmer-Smith S; Baralle D; Berry IR; Drummond J; Wallace AJ; Norbury G; Eccles DM; Ellard S; Lalloo F; Evans DG; Woodward E; Tischkowitz M; Hanson H; Turnbull C;
J Med Genet; 2020 Dec; 57(12):829-834. PubMed ID: 32170000
[TBL] [Abstract][Full Text] [Related]
20. The role of genetic counsellors in genomic healthcare in the United Kingdom: a statement by the Association of Genetic Nurses and Counsellors.
Middleton A; Marks P; Bruce A; Protheroe-Davies LK; King C; Claber O; Houghton C; Giffney C; Macleod R; Dolling C; Kenwrick S; Scotcher D; Hall G; Patch C; Boyes L
Eur J Hum Genet; 2017 Mar; 25(6):659-661. PubMed ID: 28327572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
